Stock listing
Wuhan Yzy Biopharma Co., Ltd. Class H
Selected listing: 2496 · HKEX · HKD · HK
Wuhan Yzy Biopharma Co., Ltd. Class H (HKEX:2496), Health Technology. Latest release Sep 30, 2026: DELAY IN DESPATCH OF CIRCULAR IN RELATION TO (1) CONNECTED…
- Ticker
- HKEX:2496
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- HKEX
- Currency
- HKD
About Wuhan Yzy Biopharma Co., Ltd. Class H
The company focuses on biopharmaceuticals and is dedicated to developing innovative therapies. Investors can find detailed information about its operations and performance on its public company page.
Latest news from Wuhan Yzy Biopharma Co., Ltd. Class H
DELAY IN DESPATCH OF CIRCULAR IN RELATION TO (1) CONNECTED TRANSACTION IN RESPECT OF THE PROPOSED ISSUE OF NEW DOMESTIC SHARES UNDER SPECIFIC MANDATE; (2) APPLICATION FOR WHITEWASH WAIVER; AND (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
September 30, 2026
UPDATE ON THE QUALIFICATION OF JOINT COMPANY SECRETARY AND RESIGNATION OF JOINT COMPANY SECRETARY AND CHANGE OF PROCESS AGENT
September 30, 2026
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MONDAY, JUNE 29, 2026
June 29, 2026
Research Wuhan Yzy Biopharma Co., Ltd. Class H
Wuhan Yzy Biopharma Co., Ltd. Class H company profile
View the public company page for Wuhan Yzy Biopharma Co., Ltd. Class H on 6ix.
Wuhan Yzy Biopharma Co., Ltd. Class H news
Read company news and market updates connected to Wuhan Yzy Biopharma Co., Ltd. Class H.
Wuhan Yzy Biopharma Co., Ltd. Class H investor events
Find investor webinars, events, and replay context for Wuhan Yzy Biopharma Co., Ltd. Class H.